Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: Same or different disease?

[1]  J. Slakter,et al.  TREATMENT OF POLYPOIDAL CHOROIDAL VASCULOPATHY WITH PHOTODYNAMIC THERAPY , 2012, Retina.

[2]  Lawrence A. Yannuzzi,et al.  DIGITAL INDOCYANINE GREEN VIDEOANGIOGRAPHY AND CHOROIDAL NEOVASCULARIZATION , 2012, Retina.

[3]  I. Yeo,et al.  Haemorrhagic pigment epithelial detachment as a predictive feature of polypoidal choroidal vasculopathy in a Chinese population , 2010, Eye.

[4]  Y. Tano,et al.  One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients. , 2010, Ophthalmology.

[5]  A. Negi,et al.  SOD2 gene polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy , 2009, Molecular vision.

[6]  R. Yamada,et al.  ARMS2 (LOC387715) variants in Japanese patients with exudative age-related macular degeneration and polypoidal choroidal vasculopathy. , 2009, American journal of ophthalmology.

[7]  Y. Kurimoto,et al.  Comparative Assessment of Photodynamic Therapy for Typical Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy: A Multicenter Study in Hyogo Prefecture, Japan , 2009, Ophthalmologica.

[8]  A. Negi,et al.  Coding variant I62V in the complement factor H gene is strongly associated with polypoidal choroidal vasculopathy. , 2009, Ophthalmology.

[9]  I. Yeo,et al.  A CLASSIFICATION SYSTEM FOR POLYPOIDAL CHOROIDAL VASCULOPATHY , 2009, Retina.

[10]  B. Feigl.  Age-related maculopathy – Linking aetiology and pathophysiological changes to the ischaemia hypothesis , 2008, Progress in Retinal and Eye Research.

[11]  Hiroyuki Shimada,et al.  Clinicopathologic findings in polypoidal choroidal vasculopathy. , 2008, Investigative ophthalmology & visual science.

[12]  R. Yamada,et al.  Correlation between CFH Y402H and HTRA1 rs11200638 genotype to typical exudative age‐related macular degeneration and polypoidal choroidal vasculopathy phenotype in the Japanese population , 2008, Clinical & experimental ophthalmology.

[13]  S. Fisher,et al.  Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA , 2008, Nature Genetics.

[14]  Y. Tano,et al.  Marked vascular changes of polypoidal choroidal vasculopathy after photodynamic therapy , 2008, British Journal of Ophthalmology.

[15]  A. Thalamuthu,et al.  Association analysis of CFH, C2, BF, and HTRA1 gene polymorphisms in Chinese patients with polypoidal choroidal vasculopathy. , 2008, Investigative ophthalmology & visual science.

[16]  S. Lee,et al.  The Therapeutic Effects of Bevacizumab in Patients with Polypoidal Choroidal Vasculopathy , 2008, Korean journal of ophthalmology : KJO.

[17]  H. Iijima,et al.  Association of LOC387715 A69S with vitreous hemorrhage in polypoidal choroidal vasculopathy. , 2008, American journal of ophthalmology.

[18]  Y. Tano,et al.  Polypoidal choroidal vasculopathy and treatments , 2008, Current opinion in ophthalmology.

[19]  S. C. Lee,et al.  Incidence and clinical patterns of polypoidal choroidal vasculopathy in Korean patients , 2008, Japanese Journal of Ophthalmology.

[20]  G. Rinkel,et al.  Genetics of Intracranial Aneurysms , 2008, Stroke.

[21]  Akira Negi,et al.  LOC387715/HTRA1 variants in polypoidal choroidal vasculopathy and age-related macular degeneration in a Japanese population. , 2007, American journal of ophthalmology.

[22]  N. Hamajima,et al.  Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration. , 2007, Ophthalmology.

[23]  T. Iida.  Polypoidal choroidal vasculopathy with an appearance similar to classic choroidal neovascularisation on fluorescein angiography , 2007, British Journal of Ophthalmology.

[24]  K. Fujita,et al.  Role of Photodynamic Therapy in Polypoidal Choroidal Vasculopathy , 2007, Japanese Journal of Ophthalmology.

[25]  Paul Mitchell,et al.  Clinical update: new treatments for age-related macular degeneration , 2007, The Lancet.

[26]  I. Maruko,et al.  Clinical characteristics of exudative age-related macular degeneration in Japanese patients. , 2007, American journal of ophthalmology.

[27]  Y. Tano,et al.  Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy , 2007, British Journal of Ophthalmology.

[28]  S. Kishi,et al.  TOMOGRAPHIC FEATURES OF BRANCHING VASCULAR NETWORKS IN POLYPOIDAL CHOROIDAL VASCULOPATHY , 2007, Retina.

[29]  F. Wen,et al.  Subtype lesions of neovascular age-related macular degeneration in Chinese patients , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.

[30]  T. Desmettre,et al.  Types of choroidal neovascularisation in newly diagnosed exudative age-related macular degeneration , 2007, British Journal of Ophthalmology.

[31]  Y. Tano,et al.  Angiographic lesion of polypoidal choroidal vasculopathy on indocyanine green and fluorescein angiography , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.

[32]  M. Mandai,et al.  Polypoidal choroidal vasculopathy appearing as classic choroidal neovascularisation on fluorescein angiography , 2007, British Journal of Ophthalmology.

[33]  T. Hori,et al.  A haplotype spanning two genes, ELN and LIMK1, decreases their transcripts and confers susceptibility to intracranial aneurysms. , 2006, Human molecular genetics.

[34]  Tim Clausen,et al.  The Role of Human HtrA1 in Arthritic Disease* , 2006, Journal of Biological Chemistry.

[35]  R. T. Smith,et al.  Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration , 2006, Nature Genetics.

[36]  K. Choy,et al.  Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization. , 2006, American journal of ophthalmology.

[37]  D. Clayton,et al.  Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation , 2005, British Journal of Ophthalmology.

[38]  D. Vilaplana,et al.  Fotocoagulación láser en la vasculopatía coroidal polipoidea idiopática: Seguimiento superior a un año , 2005 .

[39]  Ingrid U. Scott,et al.  Polypoidal choroidal vasculopathy: Angiographic characterization of the network vascular elements and a new treatment paradigm , 2005, Progress in Retinal and Eye Research.

[40]  R. T. Smith,et al.  A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. Cunha-Vaz,et al.  Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

[42]  J. Gilbert,et al.  Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.

[43]  A E Fletcher,et al.  28 000 Cases of age related macular degeneration causing visual loss in people aged 75 years and above in the United Kingdom may be attributable to smoking , 2005, British Journal of Ophthalmology.

[44]  M. Yuzawa,et al.  The origins of polypoidal choroidal vasculopathy , 2005, British Journal of Ophthalmology.

[45]  A. Edwards,et al.  Complement Factor H Polymorphism and Age-Related Macular Degeneration , 2005, Science.

[46]  J. Ott,et al.  Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.

[47]  Gene W. Yeo,et al.  Systematic Identification and Analysis of Exonic Splicing Silencers , 2004, Cell.

[48]  T. Lai,et al.  Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series. , 2004, Ophthalmology.

[49]  Haitao Li,et al.  Polypoidal choroidal vasculopathy in elderly Chinese patients , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.

[50]  S. Rodríguez de Córdoba,et al.  The human complement factor H: functional roles, genetic variations and disease associations. , 2004, Molecular immunology.

[51]  N. Yoshimura,et al.  Pathological features of surgically excised polypoidal choroidal vasculopathy membranes , 2004, Clinical & experimental ophthalmology.

[52]  M. Matsumura,et al.  Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy , 2004, British Journal of Ophthalmology.

[53]  N. Yoshimura,et al.  Apolipoprotein E polymorphisms in Japanese patients with polypoidal choroidal vasculopathy and exudative age-related macular degeneration. , 2004, American journal of ophthalmology.

[54]  M. Moschos,et al.  Polypoidal choroidal vasculopathy and exudative age-related macular degeneration in Greek population , 2004, Eye.

[55]  S. C. Lee,et al.  Photodynamic Therapy with Verteporfin for Polypoidal Choroidal Vasculopathy of the Macula , 2004, Ophthalmologica.

[56]  M. Mandai,et al.  Laser photocoagulation of indocyanine green angiographically identified feeder vessels to idiopathic polypoidal choroidal vasculopathy. , 2004, American journal of ophthalmology.

[57]  Benita J. O’Colmain,et al.  Prevalence of age-related macular degeneration in the United States. , 2004, Archives of ophthalmology.

[58]  M. Kawaichi,et al.  HtrA1 serine protease inhibits signaling mediated by Tgfβ family proteins , 2004, Development.

[59]  M. Matsumura,et al.  Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics. , 2003, Archives of ophthalmology.

[60]  M. Yuzawa,et al.  A study of laser photocoagulation for polypoidal choroidal vasculopathy. , 2003, Japanese journal of ophthalmology.

[61]  Y. Nose,et al.  Risk factors for age related maculopathy in a Japanese population: the Hisayama study , 2003, The British journal of ophthalmology.

[62]  Ronald Klein,et al.  The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam eye study. , 2003, Ophthalmology.

[63]  L. Yannuzzi,et al.  Polypoidal choroidal vasculopathy. , 2002, Ophthalmology clinics of North America.

[64]  M. Blumenkranz,et al.  Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3. , 2002, Archives of ophthalmology.

[65]  G. Coscas,et al.  Exudative idiopathic polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin. , 2002, American journal of ophthalmology.

[66]  M. Matsumura,et al.  Polypoidal choroidal vasculopathy: natural history. , 2002, American journal of ophthalmology.

[67]  N. Yoshimura,et al.  Polypoidal choroidal vasculopathy with large vascular network , 2002, Graefe's Archive for Clinical and Experimental Ophthalmology.

[68]  Y. Miyake,et al.  Polypoidal choroidal vasculopathy treated with macular translocation: clinical pathological correlation , 2002, The British journal of ophthalmology.

[69]  K. Takakura,et al.  Genomewide-linkage and haplotype-association studies map intracranial aneurysm to chromosome 7q11. , 2001, American journal of human genetics.

[70]  L. Yannuzzi,et al.  POLYPOIDAL CHOROIDAL VASCULOPATHY IN ITALY , 2001, Retina.

[71]  E. Friedman,et al.  The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration. , 2000, American journal of ophthalmology.

[72]  B. Lafaut,et al.  Polypoidal choroidal vasculopathy in Caucasians , 2000, Graefe's Archive for Clinical and Experimental Ophthalmology.

[73]  A. Bird,et al.  Polypoidal choroidal vasculopathy in exudative and haemorrhagic pigment epithelial detachments , 2000, The British journal of ophthalmology.

[74]  A. Bird,et al.  TIMP-3, collagen, and elastin immunohistochemistry and histopathology of Sorsby's fundus dystrophy. , 2000, Investigative ophthalmology & visual science.

[75]  L A Yannuzzi,et al.  Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration. , 1999, Archives of ophthalmology.

[76]  R Birngruber,et al.  Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study. , 1999, Archives of ophthalmology.

[77]  Kanji Takahashi,et al.  Idiopathic polypoidal choroidal vasculopathy in Japanese patients. , 1999, A M A Archives of Ophthalmology.

[78]  H. Iijima,et al.  Optical coherence tomography of idiopathic polypoidal choroidal vasculopathy. , 1999, American journal of ophthalmology.

[79]  N Orzalesi,et al.  Laser treatment of feeder vessels in subfoveal choroidal neovascular membranes: a revisitation using dynamic indocyanine green angiography. , 1998, Ophthalmology.

[80]  L. Poellinger,et al.  Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of theCBP/p300 coactivator by the hypoxia‐induciblefactor‐1α , 1998, The EMBO journal.

[81]  C. Delcourt,et al.  Smoking and age-related macular degeneration. The POLA Study. Pathologies Oculaires Liées à l'Age. , 1998, Archives of ophthalmology.

[82]  L. Yannuzzi,et al.  Idiopathic polypoidal choroidal vasculopathy of the macula. , 1998, Ophthalmology.

[83]  J. J. Wang,et al.  Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study. , 1998, Archives of ophthalmology.

[84]  F. Gómez-Ulla,et al.  DIODE LASER PHOTOCOAGULATION IN IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY , 1998, Retina.

[85]  A Hofman,et al.  Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. , 1998, Archives of ophthalmology.

[86]  L. Yannuzzi,et al.  Idiopathic polypoidal choroidal vasculopathy: a peripheral lesion. , 1998, Archives of ophthalmology.

[87]  R. Klein,et al.  The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study. , 1997, Ophthalmology.

[88]  L. Yannuzzi,et al.  The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy. , 1997, Archives of ophthalmology.

[89]  P T de Jong,et al.  An international classification and grading system for age-related maculopathy and age-related macular degeneration , 1995 .

[90]  J. Duker,et al.  Imaging of macular diseases with optical coherence tomography. , 1995, Ophthalmology.

[91]  R. Klein,et al.  The relationship of cardiovascular disease and its risk factors to age-related maculopathy. The Beaver Dam Eye Study. , 1993, Ophthalmology.

[92]  D. DeMets,et al.  The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking. , 1993, American journal of epidemiology.

[93]  J. Nyboe,et al.  Risk factor analysis for atrophic and exudative age‐related macular degeneration , 1992, Acta ophthalmologica.

[94]  R. Klein,et al.  The Wisconsin age-related maculopathy grading system. , 1991, Ophthalmology.

[95]  J. Michel,et al.  Elastase-induced experimental aneurysms in rats. , 1990, Circulation.

[96]  C. Puliafito,et al.  Indocyanine green videoangiography of choroidal neovascularization. , 1989, Ophthalmology.

[97]  J. Brody,et al.  FACTORS ASSOCIATED WITH AGE-RELATED MACULAR DEGENERATION AN ANALYSIS OF DATA FROM THE FI1R8T NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY , 1988 .

[98]  R. Sperduto,et al.  Systemic hypertension and age-related maculopathy in the Framingham Study. , 1986, Archives of ophthalmology.

[99]  Z. Zakov,et al.  Multiple recurrent serosanguineous retinal pigment epithelial detachments in black women. , 1985, American journal of ophthalmology.

[100]  W R Green,et al.  Pathologic Features of Senile Macular Degeneration , 1985, Ophthalmology.

[101]  R S Nickerson,et al.  The Framingham Eye Study. I. Outline and major prevalence findings. , 1977, American journal of epidemiology.

[102]  K. Sandvig.  CENTRAL, AREOLAR CHOROIDAL ATROPHY , 1959, Acta ophthalmologica.

[103]  R LEISHMAN,et al.  THE EYE IN GENERAL VASCULAR DISEASE HYPERTENSION AND ARTERIOSCLEROSIS* , 1957 .

[104]  I. Yeo,et al.  Argon laser photocoagulation for the treatment of polypoidal choroidal vasculopathy , 2009, Eye.

[105]  Usha Chakravarthy,et al.  The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. , 2008, Ophthalmology.

[106]  Ivana K. Kim,et al.  Cigarette smoking, CFH, APOE, ELOVL4, and risk of neovascular age-related macular degeneration. , 2007, Archives of ophthalmology.

[107]  W. A. Manschot,et al.  Retinal neovascularisation arising from hyalinised blood vessels , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

[108]  L. Yannuzzi,et al.  Polypoidal choroidal vasculopathy. , 2004, Survey of ophthalmology.

[109]  S. Harding.  Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials¿TAP Report No. 5 , 2002 .

[110]  Jennifer I. Lim,et al.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. , 2001, Archives of ophthalmology.

[111]  H. Iijima,et al.  Optical coherence tomography of orange-red subretinal lesions in eyes with idiopathic polypoidal choroidal vasculopathy. , 2000, American journal of ophthalmology.

[112]  N. Bressler,et al.  Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. , 1999, Archives of ophthalmology.

[113]  P. Mitchell,et al.  Smoking and age-related maculopathy. The Blue Mountains Eye Study. , 1996, Archives of ophthalmology.

[114]  J. Vingerling,et al.  Age-related macular degeneration and smoking. The Rotterdam Study. , 1996, A M A Archives of Ophthalmology.

[115]  J. Slakter,et al.  INDOCYANINE GREEN VIDEOANGIOGRAPHY OF IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY , 1995, Retina.

[116]  L A Yannuzzi,et al.  IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY (IPCV) , 1990, Retina.

[117]  W. Lee,et al.  Age-related retinal vasculopathy , 1987, Eye.

[118]  W. A. Manschot,et al.  Development of retinal neovascularisation in vascular occlusive disease. , 1985, Transactions of the ophthalmological societies of the United Kingdom.